Vicarious Surgical Inc. (RBOT)
| Market Cap | 5.06M -90.7% |
| Revenue (ttm) | n/a |
| Net Income | -50.18M |
| EPS | -8.19 |
| Shares Out | 7.12M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,185 |
| Average Volume | 70,958 |
| Open | 0.8050 |
| Previous Close | 0.8500 |
| Day's Range | 0.7000 - 0.8050 |
| 52-Week Range | 0.2700 - 13.7460 |
| Beta | 1.55 |
| RSI | 37.26 |
| Earnings Date | May 11, 2026 |
About Vicarious Surgical
Vicarious Surgical Inc. engages in the development and sale of single-port surgical robot in the United States. The company offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. Vicarious Surgical Inc. was founded in 2014 and is headquartered in Waltham, Massachusetts. [Read more]
Financial Performance
Financial StatementsNews
Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing
WALTHAM, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”),...
Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (OTCID: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery, today announced a series of strat...
Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCID: RBOT), a next-generation robotics technology company seeking to improve lives by transforming r...
Vicarious Surgical Receives Delisting Notice From NYSE
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today ann...
NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common st...
Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announce...
Vicarious Surgical Announces Strategic Software Execution Partnership to Streamline Operations
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today ann...
NYSE to Commence Delisting Proceedings with Respect to Warrants of Vicarious Surgical Inc. (RBOT WS)
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warran...
Vicarious Surgical Announces Full Year 2026 Cash Burn Guidance
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, ...
Vicarious Surgical Announces Reduction in 2025 Cash Burn Outlook
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, ...
Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Inc. (RBOT) Q3 2025 Earnings Call Transcript
Vicarious Surgical Inc. ( RBOT) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Stephen From - CEO & Director Sarah Romano - CFO & Treasurer Conference Call Participants Mari...
Vicarious Surgical Reports Third Quarter 2025 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 12, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 13, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Announces Pricing of $5.9 Million Registered Direct Offering
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, announced today ...
Vicarious Surgical Announces Appointment of Joseph Doherty as Chairman of The Board
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, ...
Vicarious Surgical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Inc. (RBOT) Q2 2025 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT) Q2 2025 Earnings Conference Call August 12, 2025 4:30 AM ET Company Participants Adam David Sachs - Co-Founder, President & Director Sarah Romano - CFO & Treasurer...
Vicarious Surgical Reports Second Quarter 2025 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive Officer
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, ...
Vicarious Surgical to Report Second Quarter 2025 Financial Results on August 12, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Announces Election of New Directors
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, ...
Toyota ($TM) | XPENG ($XPEV) | Innoviz ($INVZ) | Volkswagen ($VWAGY) Vicarious Surgical ($RBOT)
Welcome to the Green Stock News brief for Tuesday May 13th. Here are today's top headlines: Toyota (NYSE: TM) has unveiled its 2026 bZ Battery Electric Vehicle, featuring improved range, including a n...
Vicarious Surgical Inc. (RBOT) Q1 2025 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT) Q1 2025 Results Conference Call May 12, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Adam Sachs - Co-Founder and CEO Sarah Romano - CFO ...